6H-Pyrrolo[2,3-d]pyrimidin-6-one, 4-chloro-5,7-dihydro-7-methyl-
97%
- Product Code: 191286
CAS:
1234616-35-3
| Molecular Weight: | 183.6 g./mol | Molecular Formula: | C₇H₆ClN₃O |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD17016004 | |
| Melting Point: | Boiling Point: | 469.2±45.0 °C(Predicted) | |
| Density: | 1.474±0.06 g/cm3(Predicted) | Storage Condition: | Room temperature |
Product Description:
Used as a key intermediate in the synthesis of kinase inhibitors, particularly in the development of anticancer agents. Its structure allows for selective binding to ATP sites in protein kinases, making it valuable in targeted therapies for leukemia and other malignancies. Also employed in research for antiviral drug design due to its ability to mimic purine bases. Commonly modified to enhance solubility and bioavailability in pharmaceutical formulations.
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 0.100 G | 10-20 days | ฿3,420.00 |
+
-
|
| 0.500 G | 10-20 days | ฿8,300.00 |
+
-
|
6H-Pyrrolo[2,3-d]pyrimidin-6-one, 4-chloro-5,7-dihydro-7-methyl-
Used as a key intermediate in the synthesis of kinase inhibitors, particularly in the development of anticancer agents. Its structure allows for selective binding to ATP sites in protein kinases, making it valuable in targeted therapies for leukemia and other malignancies. Also employed in research for antiviral drug design due to its ability to mimic purine bases. Commonly modified to enhance solubility and bioavailability in pharmaceutical formulations.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :